Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q57557257 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000318.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q57557257 | ||
| 024 | ‡a 0000-0002-6928-078X ‡2 orcid | ||
| 024 | ‡a 55485775600 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q57557257 | ||
| 100 | 0 | ‡a Aline Lima Oliveira ‡c researcher ORCID ID = 0000-0002-6928-078X ‡9 en | |
| 400 | 0 | ‡a Aline Lima Oliveira ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Initial growth and physiology of guanandi (<i>Calophyllum brasiliense</i> Cambess) seedlings treated with humic acids and aqueous vermicompost extract | ||
| 670 | ‡a Author's Intragenic antimicrobial peptides (IAPs) from human proteins with potent antimicrobial and anti-inflammatory activity | ||
| 670 | ‡a Author's NMR structures and molecular dynamics simulation of hylin-a1 peptide analogs interacting with micelles | ||
| 670 | ‡a Author's Purified citritin in combination with vancomycin inhibits VRE in vitro and in vivo. | ||
| 670 | ‡a Author's Structural Studies of a Lipid-Binding Peptide from Tunicate Hemocytes with Anti-Biofilm Activity | ||
| 909 | ‡a (scopus) 55485775600 ‡9 1 | ||
| 909 | ‡a (orcid) 000000026928078x ‡9 1 | ||
| 919 | ‡a nmrstructuresandmoleculardynamicssimulationofhylina1peptideanalogsinteractingwithmicelles ‡A NMR structures and molecular dynamics simulation of hylin-a1 peptide analogs interacting with micelles ‡9 1 | ||
| 919 | ‡a structuralstudiesofalipidbindingpeptidefromtunicatehemocyteswithantibiofilmactivity ‡A Structural Studies of a Lipid-Binding Peptide from Tunicate Hemocytes with Anti-Biofilm Activity ‡9 1 | ||
| 919 | ‡a initialgrowthandphysiologyofguanandi1calophyllumbrasiliense1cambessseedlingstreatedwithhumicacidsandaqueousvermicompostextract ‡A Initial growth and physiology of guanandi (<i>Calophyllum brasiliense</i> Cambess) seedlings treated with humic acids and aqueous vermicompost extract ‡9 1 | ||
| 919 | ‡a intragenicantimicrobialpeptidesiapsfromhumanproteinswithpotentantimicrobialandantiinflammatoryactivity ‡A Intragenic antimicrobial peptides (IAPs) from human proteins with potent antimicrobial and anti-inflammatory activity ‡9 1 | ||
| 919 | ‡a purifiedcitritinincombinationwithvancomycininhibitsvreinvitroandinvivo ‡A Purified citritin in combination with vancomycin inhibits VRE in vitro and in vivo. ‡9 1 | ||
| 996 | ‡2 ISNI|0000000067816136 | ||
| 996 | ‡2 PTBNP|84695 | ||
| 996 | ‡2 PTBNP|35247 | ||
| 996 | ‡2 PTBNP|223235 | ||
| 996 | ‡2 NTA|074363263 | ||
| 996 | ‡2 PTBNP|96247 | ||
| 996 | ‡2 ISNI|000000006941208X | ||
| 996 | ‡2 ISNI|0000000070998794 | ||
| 996 | ‡2 PTBNP|158549 | ||
| 996 | ‡2 ISNI|0000000070115760 | ||
| 996 | ‡2 BLBNB|000460997 | ||
| 996 | ‡2 LC|n 2021251968 | ||
| 996 | ‡2 ISNI|0000000068209696 | ||
| 996 | ‡2 PTBNP|1616903 | ||
| 996 | ‡2 DNB|1340519518 | ||
| 996 | ‡2 LC|n 2010204423 | ||
| 996 | ‡2 J9U|987007375953605171 | ||
| 996 | ‡2 PTBNP|173541 | ||
| 996 | ‡2 PTBNP|64242 | ||
| 996 | ‡2 DNB|1089095309 | ||
| 996 | ‡2 SELIBR|81474 | ||
| 996 | ‡2 SUDOC|081778848 | ||
| 996 | ‡2 PTBNP|147272 | ||
| 996 | ‡2 NTA|069981256 | ||
| 996 | ‡2 BLBNB|000310166 | ||
| 996 | ‡2 BLBNB|001587182 | ||
| 996 | ‡2 BLBNB|001510802 | ||
| 996 | ‡2 DNB|1157175430 | ||
| 996 | ‡2 BLBNB|001570204 | ||
| 996 | ‡2 PTBNP|222089 | ||
| 996 | ‡2 ISNI|0000000068917107 | ||
| 996 | ‡2 ISNI|0000000456429930 | ||
| 996 | ‡2 NSK|000648909 | ||
| 996 | ‡2 DNB|120594415X | ||
| 996 | ‡2 PTBNP|286169 | ||
| 996 | ‡2 PTBNP|78409 | ||
| 996 | ‡2 PTBNP|45599 | ||
| 996 | ‡2 ISNI|0000000066435593 | ||
| 996 | ‡2 LC|n 2023251720 | ||
| 996 | ‡2 LC|n 2023253856 | ||
| 996 | ‡2 PTBNP|207368 | ||
| 996 | ‡2 SUDOC|078647045 | ||
| 996 | ‡2 PTBNP|1850283 | ||
| 996 | ‡2 ISNI|0000000066328819 | ||
| 996 | ‡2 LC|no 98110184 | ||
| 996 | ‡2 PTBNP|1006496 | ||
| 996 | ‡2 ISNI|0000000067416896 | ||
| 996 | ‡2 CAOONL|ncf11871516 | ||
| 996 | ‡2 PTBNP|45587 | ||
| 996 | ‡2 PTBNP|937603 | ||
| 996 | ‡2 PTBNP|1147450 | ||
| 996 | ‡2 LC|no 94000870 | ||
| 996 | ‡2 ISNI|0000000079707439 | ||
| 996 | ‡2 ISNI|0000000068706174 | ||
| 996 | ‡2 PTBNP|1169734 | ||
| 996 | ‡2 PTBNP|1356952 | ||
| 996 | ‡2 BLBNB|000518973 | ||
| 996 | ‡2 PLWABN|9813655953005606 | ||
| 996 | ‡2 BLBNB|001523910 | ||
| 996 | ‡2 LC|n 2024047871 | ||
| 996 | ‡2 BLBNB|000423929 | ||
| 996 | ‡2 ISNI|0000000108489662 | ||
| 996 | ‡2 PTBNP|189773 | ||
| 996 | ‡2 PTBNP|209202 | ||
| 996 | ‡2 ISNI|0000000068697597 | ||
| 996 | ‡2 LC|n 84173112 | ||
| 996 | ‡2 ISNI|0000000069730301 | ||
| 996 | ‡2 RERO|A003654830 | ||
| 996 | ‡2 RERO|A003654831 | ||
| 996 | ‡2 ISNI|0000000400223132 | ||
| 996 | ‡2 LC|n 2022253232 | ||
| 996 | ‡2 ISNI|0000000046619627 | ||
| 996 | ‡2 SUDOC|096137991 | ||
| 996 | ‡2 BLBNB|001590462 | ||
| 996 | ‡2 LC|n 2013182553 | ||
| 996 | ‡2 LC|n 88157595 | ||
| 996 | ‡2 LC|n 2012211240 | ||
| 996 | ‡2 NSK|000710262 | ||
| 996 | ‡2 BLBNB|001428704 | ||
| 996 | ‡2 PTBNP|45932 | ||
| 996 | ‡2 BLBNB|000529916 | ||
| 996 | ‡2 NUKAT|n 2018244664 | ||
| 996 | ‡2 DNB|1342873939 | ||
| 996 | ‡2 ISNI|0000000069320329 | ||
| 996 | ‡2 NUKAT|n 2014055538 | ||
| 996 | ‡2 ISNI|000000002611869X | ||
| 996 | ‡2 BLBNB|001439283 | ||
| 996 | ‡2 ISNI|000000006979193X | ||
| 996 | ‡2 BLBNB|000528370 | ||
| 996 | ‡2 NII|DA06662653 | ||
| 996 | ‡2 ISNI|0000000418120668 | ||
| 996 | ‡2 BLBNB|001588466 | ||
| 996 | ‡2 ISNI|0000000359265962 | ||
| 996 | ‡2 BNF|12073578 | ||
| 996 | ‡2 PTBNP|147256 | ||
| 996 | ‡2 J9U|987007265187805171 | ||
| 996 | ‡2 PTBNP|45944 | ||
| 996 | ‡2 PTBNP|45947 | ||
| 996 | ‡2 PTBNP|225536 | ||
| 996 | ‡2 PTBNP|1558536 | ||
| 996 | ‡2 LC|no2012067248 | ||
| 996 | ‡2 ISNI|000000007903430X | ||
| 996 | ‡2 ISNI|0000000068113432 | ||
| 996 | ‡2 ISNI|0000000121452143 | ||
| 996 | ‡2 PTBNP|44746 | ||
| 996 | ‡2 LC|no2024029902 | ||
| 996 | ‡2 LC|n 2024251920 | ||
| 996 | ‡2 BLBNB|000328562 | ||
| 996 | ‡2 BLBNB|000507243 | ||
| 996 | ‡2 ISNI|0000000069689337 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
